← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

#	Name	Funds holding	Growth	Growth %	Fund value
1	1 Pfizer PFE $169B	2,244	+202	+10%	$154B
2	2 Amgen AMGN $238B	1,735	+129	+8%	$99.8B
3	3 Eli Lilly LLY $1.13T	1,373	+144	+12%	$72B
4	4 Becton Dickinson BDX $52.4B	1,238	+170	+16%	$47.8B
5	5 McKesson MCK $116B	927	+50	+6%	$28.6B
6	6 Conagra Brands CAG $6.84B	711	+48	+7%	$12.1B
7	7 Regeneron Pharmaceuticals REGN $82.9B	639	+33	+5%	$26.9B
8	8 Novo Nordisk NVO $174B	552	+61	+12%	$8.83B
9	9 Teva Pharmaceutical Industries Limited TEVA $48.2B	508	-29	-5%	$11.2B
10	10 Lamb Weston LW $7.46B	506	+49	+11%	$6.68B
11	11 AstraZeneca AZN $260B	504	+48	+11%	$13.4B
12	12 DaVita DVA $11.9B	479	+36	+8%	$11.4B
13	13 ResMed RMD $33.8B	416	+53	+15%	$7.57B
14	14 West Pharmaceutical WST $26.9B	338	+36	+12%	$6.89B
15	15 DELISTED CATALENT, INC. CTLT	276	-10	-3%	$5.48B
16	16 Opko Health OPK $1.18B	232	-2	-0.9%	$644M
17	17 Accendra Health ACH $22M	230	-30	-12%	$1.13B
18	18 Fresenius Medical Care FMS $11.8B	220	+15	+7%	$779M
19	19 Herbalife HLF $1.52B	204	+11	+6%	$5.89B
20	20 Medifast MED $136M	201	+33	+20%	$736M
21	21 DELISTED WW International WW	194	+26	+15%	$2.64B
22	22 Tootsie Roll Industries TR $2.92B	178	+16	+10%	$500M
23	TWNK 23 DELISTED Hostess Brands, Inc. Class A Common Stock TWNK	158	+25	+19%	$1.56B
24	24 Lexicon Pharmaceuticals LXRX $725M	133	-4	-3%	$1.1B
25	25 Alaunos Therapeutics TCRT $5.28M	128	+6	+5%	$237M